rs1554809516
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_001114753.3(ENG):c.1220G>A(p.Ser407Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001114753.3 missense
Scores
Clinical Significance
Conservation
Publications
- telangiectasia, hereditary hemorrhagic, type 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, ClinGen
- hereditary hemorrhagic telangiectasiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- juvenile polyposis syndromeInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ENG | NM_001114753.3 | c.1220G>A | p.Ser407Asn | missense_variant | Exon 9 of 15 | ENST00000373203.9 | NP_001108225.1 | |
| ENG | NM_000118.4 | c.1220G>A | p.Ser407Asn | missense_variant | Exon 9 of 14 | NP_000109.1 | ||
| ENG | NM_001278138.2 | c.674G>A | p.Ser225Asn | missense_variant | Exon 9 of 15 | NP_001265067.1 | ||
| LOC102723566 | NR_136302.1 | n.1568+1241C>T | intron_variant | Intron 4 of 5 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ENG | ENST00000373203.9 | c.1220G>A | p.Ser407Asn | missense_variant | Exon 9 of 15 | 1 | NM_001114753.3 | ENSP00000362299.4 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Telangiectasia, hereditary hemorrhagic, type 1 Pathogenic:1
- -
Hereditary hemorrhagic telangiectasia Pathogenic:1
In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Experimental studies using activated monocytes isolated from a carrier individual indicate that this variant leads to a defect in the maturation of the ENG protein and its traffic to the cell membrane. However, transient over-expression experiments using HeLa cells in culture show that it does not interfere with protein transport into the cell membrane in that system (PMID: 22022569). The clinical relevance of these findings is uncertain. This variant has been reported in several individuals affected with hereditary hemorrhagic telangiectasia and to segregate with the disease in one family (PMID: 11440987, 16542389 , 16690726 , 22991266). This variant is not present in population databases (ExAC no frequency). This sequence change replaces serine with asparagine at codon 407 of the ENG protein (p.Ser407Asn). The serine residue is moderately conserved and there is a small physicochemical difference between serine and asparagine. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at